Mife Plus Miso or Miso-Alone for Abortion Induction in Pregnancies 12–24 Weeks’ LMP
- February 1st, 2014
- Clinical Guidelines
- Medication Abortion
- Gynuity Health Projects
Gynuity Health Projects convened an expert meeting in 2013 looking at the use of mifepristone and misoprostol for abortion induction in pregnancies 12-24 weeks’ LMP. Professionals with epidemiological, clinical and programmatic expertise reached consensus on the appropriate use of mifepristone and misoprostol or misoprostol-alone for termination of pregnancies with a live fetus. The results were compiled in a brochure called “Instructions for Use – (IFU).” The information in this document may serve as a basis for the development of clinical practice guidelines and patient and provider education materials.